GO:0039695 DNA-templated viral transcription: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0039695 (DNA-templated viral transcription) is defined as a transcription process that uses a viral DNA as a template [QuickGO].
• This process is essential for the replication of DNA viruses and for the expression of viral genes that drive pathogenesis.
• Key enzymes include viral DNA-dependent RNA polymerases and host RNA polymerases that are redirected to viral templates.
• Studying this process informs antiviral drug development and the engineering of viral vectors for gene therapy.
• CRISPR-based knockout, knock-in, and point-mutation models enable precise dissection of viral and host factors involved.
• Advanced methods such as ribosome profiling and in vitro transcription assays reveal mechanistic details and kinetics.
Description
DNA-templated viral transcription (GO:0039695) is the process by which RNA is synthesized using a viral DNA template. This ontology term captures a critical step in the life cycle of DNA viruses, including those that cause significant human diseases such as hepatitis B, herpes simplex, and poxvirus infections. Understanding this process is fundamental for elucidating viral replication strategies and for developing antiviral therapeutics that target viral transcription. The term is also relevant for biotechnology applications, where viral DNA-templated transcription systems, such as T7 RNA polymerase, are harnessed for mRNA synthesis. Recent advances in structural biology and single-molecule kinetics have provided detailed insights into the molecular mechanisms of viral transcription, revealing how viral and host factors cooperate to transcribe viral DNA. This article synthesizes current knowledge on the mechanisms, key genes, regulatory networks, and research methodologies associated with DNA-templated viral transcription, with a focus on how CRISPR-based models can accelerate discovery.
DNA-templated viral transcription At A Glance
| GO ID | GO:0039695 |
|---|---|
| GO term | DNA-templated viral transcription |
| Ontology | biological_process |
| Synonym | None |
| Definition | A transcription process that uses a viral DNA as a template. |
| Major function | Synthesis of viral RNA from viral DNA templates, enabling viral gene expression and replication. |
| Related processes | Viral replication, host-pathogen interaction, antiviral response. |
| Key enzymes | Viral RNA polymerases, host RNA polymerase II, T7 RNA polymerase (in engineered systems). |
| Disease relevance | Viral infections (e.g., hepatitis B, herpes, poxvirus), antiviral drug targets. |
What Is GO:0039695?
According to the Gene Ontology, DNA-templated viral transcription (GO:0039695) is a transcription process that uses a viral DNA as a template. This definition encompasses the synthesis of RNA from a DNA template of viral origin, whether the RNA polymerase is virally encoded or host-derived. The term is a child of DNA-templated transcription (GO:0006351) and is specific to viral templates, distinguishing it from host gene transcription. It includes both early and late viral gene expression and can occur in the nucleus or cytoplasm depending on the virus. The process is essential for the production of viral mRNAs, which are translated into viral proteins, and for the generation of genomic RNA for some viruses.
Why Is DNA-templated viral transcription Important in Cell Biology?
DNA-templated viral transcription is a central step in the life cycle of DNA viruses and is a validated target for antiviral therapies. Many clinically important viruses, such as hepatitis B virus (HBV), herpes simplex virus (HSV), and human cytomegalovirus (HCMV), rely on DNA-templated transcription for their replication and pathogenesis. Inhibitors of viral transcription, such as nucleoside analogs, are mainstays of antiviral treatment. Moreover, the machinery of DNA-templated viral transcription, particularly bacteriophage RNA polymerases like T7, is widely used in biotechnology for the in vitro synthesis of mRNA therapeutics and vaccines. Thus, understanding the molecular details of this process has broad implications for human health and biotechnology.
• Essential for the replication of DNA viruses, including herpesviruses, adenoviruses, and poxviruses.
• Provides targets for antiviral drugs, such as inhibitors of viral DNA polymerase and transcription factors.
• Underpins the production of viral mRNA, which is translated into proteins that drive pathogenesis.
• Enables the development of viral vectors for gene therapy and vaccines.
• Facilitates the industrial synthesis of mRNA using phage RNA polymerases like T7.
• Involved in the regulation of host immune responses through viral RNA sensing.
• Key to understanding viral latency and reactivation, as seen in herpesviruses.
• Offers a model system for studying transcription mechanisms and kinetics.
• Enables high-throughput screening for antiviral compounds targeting viral transcription.
• Provides insights into virus-host coevolution and host range determinants.
What Happens During DNA-templated viral transcription?
Initiation of Viral Transcription
In simple terms: The process starts when an RNA polymerase binds to a specific DNA sequence in the viral genome and opens the DNA double helix.
Initiation of DNA-templated viral transcription requires the recognition of viral promoter sequences by either viral or host RNA polymerases. For many DNA viruses, viral transcription factors and host RNA polymerase II are recruited to viral promoters to form a preinitiation complex. In the case of bacteriophage T7, the T7 RNA polymerase binds to a specific promoter sequence and initiates transcription without the need for host factors. The kinetics of initiation have been studied using in vitro transcription systems, revealing that promoter binding and DNA melting are critical steps. The efficiency of initiation can be modulated by viral proteins and host factors, influencing the overall rate of viral gene expression.
Elongation and RNA Synthesis
In simple terms: After initiation, the RNA polymerase moves along the viral DNA, adding nucleotides to the growing RNA chain.
During elongation, the RNA polymerase synthesizes RNA complementary to the viral DNA template. This process is highly processive and can be regulated by elongation factors. For example, the hepatitis delta virus (HDV) RNA is transcribed by host RNA polymerase II, and the elongation step is influenced by the viral delta antigen. In vitro studies with T7 RNA polymerase have shown that elongation rates can be affected by DNA sequence and template topology. The synthesized RNA can be capped, spliced, and polyadenylated, depending on the virus and the RNA polymerase involved.
Termination and RNA Release
In simple terms: The polymerase stops at specific signals and releases the newly made RNA.
Termination of DNA-templated viral transcription occurs at specific termination signals, which can be intrinsic (hairpin structures) or factor-dependent. For T7 RNA polymerase, termination is often mediated by a hairpin structure in the nascent RNA. In eukaryotic viruses, termination is coupled to polyadenylation and involves host factors. The released RNA is then processed and exported for translation or packaged into virions. The efficiency of termination can impact the yield of full-length viral transcripts and is a target for antiviral intervention.
Regulation by Viral and Host Factors
In simple terms: Both viral proteins and host cell proteins can turn transcription up or down.
DNA-templated viral transcription is regulated by a complex interplay of viral and host factors. Viral transactivators, such as the herpes simplex virus VP16 protein, recruit host coactivators to viral promoters. Conversely, host restriction factors can inhibit viral transcription. For instance, the interferon-inducible protein IFI16 can sense viral DNA and repress transcription. Additionally, post-translational modifications of histones on viral DNA can influence transcription. Understanding these regulatory mechanisms is crucial for developing therapies that modulate viral transcription.
Coupling to Viral Replication and Assembly
In simple terms: Transcription is often coordinated with viral DNA replication and the assembly of new virus particles.
In many DNA viruses, transcription is temporally regulated and coupled to viral DNA replication. Early genes are transcribed before replication, while late genes are transcribed after replication begins. This temporal control ensures the ordered expression of viral proteins. For example, in adenoviruses, the major late promoter is activated after DNA replication, leading to high-level expression of structural proteins. The coupling of transcription to replication and assembly is mediated by viral and host factors and is essential for efficient virion production.
Key Genes Involved in GO:0039695 DNA-templated viral transcription
The following genes and proteins are key players in DNA-templated viral transcription, including viral RNA polymerases, host transcription factors, and regulatory proteins.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR2A | Host RNA polymerase II subunit; transcribes viral DNA in eukaryotic viruses | Target for antiviral drugs; knockout studies reveal host dependency |
| T7 RNA polymerase (gene 1) | Bacteriophage RNA polymerase; highly processive DNA-templated transcription | Engineered for mRNA synthesis; used in in vitro transcription |
| HBV polymerase | Viral reverse transcriptase and DNA polymerase; also involved in transcription | Target of nucleoside analogs for hepatitis B |
| HSV-1 VP16 | Viral transactivator; recruits host transcription machinery | Model for studying viral gene regulation |
| HDV delta antigen | Regulates HDV RNA transcription by host RNA polymerase II | Studied for RNA-dependent transcription mechanisms |
| IFI16 | Host DNA sensor; restricts viral transcription | Innate immunity factor; knockout increases viral replication |
| TBP | TATA-binding protein; part of host preinitiation complex | Essential for viral and host transcription |
| TFIIB | General transcription factor; recruits RNA polymerase II | Target for viral hijacking |
| Mediator complex | Bridges transcription factors and RNA polymerase II | Integrates viral and host signals |
| CTD of POLR2A | C-terminal domain; regulates transcription elongation and processing | Phosphorylation state affects viral transcription |
| Flock House virus RNA1 | Encodes RNA-dependent RNA polymerase; also has DNA-templated transcription activity? | Model for viral replication |
| T7 lysozyme | Inhibits T7 RNA polymerase; regulates transcription | Used in controlled expression systems |
| TALE proteins | Engineered DNA-binding proteins; can be used to target viral DNA | Redesigned for DNA-templated assembly |
| Reverse transcriptase | Converts RNA to DNA; in retroviruses, also involved in transcription | Target for HIV drugs |
| RNA polymerase I | Transcribes ribosomal RNA; some viruses use it for viral RNA | Host factor for certain viruses |
| RNA polymerase III | Transcribes small RNAs; may transcribe viral DNA | Host factor for some DNA viruses |
| c-Myc | Host oncogene; can activate viral transcription | Implicated in virus-associated cancers |
| NF-κB | Host transcription factor; activates viral promoters | Inflammatory signaling in viral infection |
How Is DNA-templated viral transcription Regulated?
DNA-templated viral transcription is regulated at multiple levels, including promoter recognition, transcription factor availability, and epigenetic modifications of viral DNA. Host signaling pathways, such as NF-κB and interferon pathways, can modulate viral transcription by altering the activity of transcription factors. Viral proteins can also feedback to regulate their own transcription. For example, the hepatitis B virus X protein (HBx) stimulates viral transcription by activating host transcription factors. Additionally, the phosphorylation state of the RNA polymerase II C-terminal domain (CTD) controls the transition from initiation to elongation and is targeted by viral proteins. In the case of bacteriophage T7, transcription is regulated by the availability of T7 lysozyme, which inhibits the RNA polymerase. Understanding these regulatory mechanisms is essential for developing strategies to control viral infections.
DNA-templated viral transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HBV polymerase | Hepatitis B, hepatocellular carcinoma | HBV-infected hepatocyte cell lines; CRISPR knockout of POLR2A |
| HSV-1 VP16 | Herpes simplex encephalitis, cold sores | Neuronal cell lines; point mutations in VP16 |
| HPV E6/E7 | Cervical cancer, head and neck cancer | HeLa cells; CRISPR knockout of E6/E7 |
| IFI16 | Innate immune response to viral DNA | Knockout mice or THP-1 cells; overexpression studies |
| T7 RNA polymerase | mRNA vaccine production | Engineered E. coli or cell-free systems; point mutations for improved properties |
Viral Infections and Antiviral Targets
DNA-templated viral transcription is essential for the replication of many human pathogens, including hepatitis B virus (HBV), herpes simplex virus (HSV), and human cytomegalovirus (HCMV). Inhibitors of viral transcription, such as nucleoside analogs (e.g., acyclovir for HSV, entecavir for HBV), are effective antiviral drugs. These drugs target viral DNA polymerase or reverse transcriptase, which are also involved in transcription. Understanding the molecular details of viral transcription can lead to new antiviral therapies, especially for drug-resistant strains.
Virus-Associated Cancers
Several DNA viruses are oncogenic, and their transcription programs contribute to cellular transformation. For example, human papillomavirus (HPV) E6 and E7 proteins, which are transcribed from viral DNA, inactivate tumor suppressors p53 and Rb, leading to cervical cancer. Hepatitis B virus (HBV) chronic infection is a major risk factor for hepatocellular carcinoma, partly through the activity of the HBx protein, which modulates viral and host transcription. Targeting viral transcription may therefore have therapeutic potential in virus-associated cancers.
Biotechnology and mRNA Therapeutics
DNA-templated viral transcription is harnessed in biotechnology for the in vitro synthesis of mRNA. Bacteriophage T7 RNA polymerase is widely used to produce mRNA for vaccines and therapeutics, including COVID-19 mRNA vaccines. Engineering T7 RNA polymerase to reduce immunostimulatory byproducts has improved the safety and efficacy of mRNA therapeutics. Thus, understanding the mechanism of DNA-templated viral transcription directly impacts the development of next-generation mRNA medicines.
From DNA-templated viral transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does host RNA polymerase II mediate viral transcription? | Knockout of POLR2A in permissive cells, followed by viral infection |
| What is the role of a specific viral transcription factor? | Point mutation or knockout of the viral gene in a reverse genetics system |
| Can a host factor be targeted to inhibit viral transcription? | Knockout or knockdown of the host gene, then measure viral RNA |
| How does a mutation affect viral transcription kinetics? | Knock-in of the mutant gene into the viral genome, then in vitro transcription assays |
| Can we engineer a viral polymerase for improved mRNA synthesis? | Overexpression of engineered T7 RNA polymerase in E. coli, followed by in vitro transcription |
| What is the effect of a drug on viral transcription? | Overexpression of viral transcription factors in reporter cell lines, then drug treatment |
How to Study the DNA-templated viral transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro transcription | RNA synthesis rate, promoter specificity | Studying T7 RNA polymerase kinetics |
| Ribosome profiling | Translation of viral mRNAs | Plant virus infection |
| CRISPR knockout screen | Host genes required for viral transcription | Identify antiviral targets |
| RNA-seq | Viral and host transcript levels | Quantify viral gene expression |
| ChIP-seq | RNA polymerase and transcription factor binding | Map viral promoters |
| Single-molecule imaging | Real-time transcription dynamics | T7 RNA polymerase mechanism |
| Mass spectrometry | Protein interactions in transcription complexes | Identify host factors in viral transcription |
| Reporter assays | Promoter activity | Screen antiviral compounds |
In Vitro Transcription Assays
In vitro transcription assays using purified RNA polymerases and DNA templates are fundamental for studying DNA-templated viral transcription. These assays allow precise control of reaction components and can measure kinetics, processivity, and inhibitor effects. For example, T7 RNA polymerase is commonly used in such assays to study promoter recognition and elongation. The assays can be coupled with gel electrophoresis or fluorescence to quantify RNA products.
Ribosome Profiling
Ribosome profiling (Ribo-seq) measures translation at codon resolution and can be used to study the translation of viral mRNAs produced by DNA-templated viral transcription. In plants, ribosome profiling has been adapted to study viral infection and host translation. This method reveals which viral transcripts are actively translated and how viral transcription affects host translation. It is particularly useful for understanding the interplay between viral transcription and translation during infection.
CRISPR-Based Genetic Screens
CRISPR knockout and activation screens can identify host genes that regulate DNA-templated viral transcription. For example, a genome-wide CRISPR screen could identify host factors required for HBV transcription. Such screens have been used to discover antiviral targets and to map virus-host interactions. The use of CRISPR libraries enables unbiased discovery of genes that either promote or restrict viral transcription.
Imaging and Single-Molecule Approaches
Advanced imaging techniques, such as single-molecule fluorescence, can visualize viral transcription in real time. These methods have been used to study the dynamics of T7 RNA polymerase on DNA templates. Additionally, live-cell imaging of viral DNA and RNA can reveal the spatiotemporal organization of viral transcription factories. Such approaches provide insights into the kinetics and regulation of viral transcription in infected cells.
How CRISPR Can Be Used to Study GO:0039695 DNA-templated viral transcription
Knockout
CRISPR knockout of host genes can reveal essential factors for DNA-templated viral transcription. For example, knocking out POLR2A or other general transcription factors can abolish viral transcription and replication. Knockout of viral genes themselves, using reverse genetics, can also be achieved with CRISPR if the viral genome is maintained in a bacterial artificial chromosome (BAC). These models help determine whether a gene is required for viral transcription and pathogenesis.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in viral or host transcription factors to dissect their function. For instance, mutating the catalytic residues of T7 RNA polymerase can abolish transcription, while mutations in promoter recognition domains alter specificity. Point mutations in host factors, such as the CTD of POLR2A, can reveal phosphorylation sites critical for viral transcription. These models are valuable for understanding structure-function relationships.
Knock-in
CRISPR knock-in can be used to tag endogenous viral or host genes with fluorescent or affinity tags to study their localization and interactions during viral transcription. For example, knocking in a GFP tag on the HBV polymerase can allow live-cell imaging of viral transcription complexes. Knock-in of reporter genes under viral promoters can also be used to monitor transcription in real time. These models provide insights into the dynamics of viral transcription in living cells.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression can be used to increase the levels of viral or host transcription factors to study their effects on viral transcription. Overexpression of T7 RNA polymerase in E. coli is used for high-yield mRNA synthesis. Overexpression of host factors like NF-κB can enhance viral transcription and may model virus-associated cancers. These approaches help identify rate-limiting factors and potential therapeutic targets.
How EDITGENE Supports DNA-templated viral transcription Research
Researchers studying DNA-templated viral transcription-related genes often need to determine whether a candidate gene is causally involved in viral replication or pathogenesis. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides comprehensive services to generate such models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for DNA-templated viral transcription research.
Frequently Asked Questions About DNA-templated viral transcription
What is DNA-templated viral transcription?
DNA-templated viral transcription (GO:0039695) is the process of synthesizing RNA using a viral DNA template, essential for the replication of DNA viruses.
What genes are involved in DNA-templated viral transcription?
Key genes include POLR2A (host RNA polymerase II), viral polymerases like HBV polymerase, and transcription factors such as VP16 and NF-κB.
How is DNA-templated viral transcription regulated?
It is regulated by viral transactivators, host transcription factors, epigenetic modifications, and signaling pathways like NF-κB and interferon.
Why is DNA-templated viral transcription important for antiviral drug development?
Many antiviral drugs target viral transcription enzymes, such as nucleoside analogs that inhibit viral polymerases.
What methods are used to study DNA-templated viral transcription?
Common methods include in vitro transcription assays, ribosome profiling, CRISPR screens, and single-molecule imaging.
Can CRISPR be used to study DNA-templated viral transcription?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of viral and host factors.
What is the role of T7 RNA polymerase in DNA-templated viral transcription?
T7 RNA polymerase is a bacteriophage enzyme that transcribes DNA templates and is widely used for in vitro mRNA synthesis.
How does hepatitis B virus use DNA-templated transcription?
HBV uses host RNA polymerase II to transcribe its DNA genome, and its polymerase is a target for antiviral drugs.
What diseases are associated with defects in DNA-templated viral transcription?
Viral infections such as hepatitis, herpes, and HPV-associated cancers involve this process.
What are the current challenges in targeting DNA-templated viral transcription?
Challenges include drug resistance, toxicity, and the need for virus-specific inhibitors that do not affect host transcription.
Conclusion
DNA-templated viral transcription (GO:0039695) is a fundamental biological process that enables DNA viruses to express their genes and replicate. It is a validated target for antiviral drugs and a key tool in biotechnology for mRNA synthesis. Understanding its mechanisms, regulation, and disease relevance is essential for developing new therapies and vaccines. CRISPR-based models and advanced screening methods are accelerating discoveries in this field, and EDITGENE offers comprehensive services to support such research.
References
- 1. Dousis A et al.. 2023. An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts.. Nat Biotechnol 41(4):560-568 PMID: 36357718
- 2. Sonia J et al.. 2024. Ribosome Profiling of Plants.. Methods Mol Biol 2724:139-163 PMID: 37987904
- 3. de Haas RJ et al.. 2026. Redesign of TALE proteins for DNA-templated assembly of protein fibers.. Nat Commun 17(1) PMID: 42156388
- 4. Le Grice SF. 2012. Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.. J Biol Chem 287(49):40850-7 PMID: 23043108
- 5. Stover NM et al.. 2026. Systems analysis of the kinetics of in vitro transcription from interactions of T7 RNA polymerase and DNA.. Arch Biochem Biophys 778:110737 PMID: 41548703
- 6. Johnson KL et al.. 1999. Induction and maintenance of autonomous flock house virus RNA1 replication.. J Virol 73(10):7933-42 PMID: 10482540
- 8. Modahl LE et al.. 2000. RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.. Mol Cell Biol 20(16):6030-9 PMID: 10913185
